[HTML][HTML] SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses

…, RS Sankhala, WH Chen, WC Chang, JS Bolton… - npj Vaccines, 2021 - nature.com
The emergence of variants of concern, some with reduced susceptibility to COVID-19
vaccines underscores consideration for the understanding of vaccine design that optimizes …

[HTML][HTML] SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies

…, WC Chang, J King, C Corbitt, S Mayer, JS Bolton… - npj Vaccines, 2023 - nature.com
This study demonstrates the impact of adjuvant on the development of T follicular helper (Tfh)
and B cells, and their influence on antibody responses in mice vaccinated with SARS-CoV-…

[HTML][HTML] Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS, S malaria …

S Chaudhury, RS MacGill, AM Early, JS Bolton… - Vaccine, 2021 - Elsevier
The circumsporozoite protein (CSP) is the main surface antigen of malaria sporozoites, a
prime vaccine target, and is known to have polymorphisms in the C-terminal region. Vaccines …

[HTML][HTML] Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination

JS Bolton, S Chaudhury, S Dutta, S Gregory, E Locke… - Malaria journal, 2020 - Springer
Background Profiling immune responses induced by either infection or vaccination can provide
insight into identification of correlates of protection. Furthermore, profiling of serological …

[HTML][HTML] Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform

S Chaudhury, J Hutter, JS Bolton, S Hakre, E Mose… - PLoS …, 2021 - journals.plos.org
Serological assessment of SARS-CoV-2 specific responses are an essential tool for determining
the prevalence of past SARS-CoV-2 infections in the population especially when testing …

[HTML][HTML] Novel antibody competition binding assay identifies distinct serological profiles associated with protection

JS Bolton, RS MacGill, E Locke, JA Regules… - Frontiers in …, 2023 - frontiersin.org
Introduction Pre-erythrocytic malaria vaccines hold the promise of inducing sterile protection
thereby preventing the morbidity and mortality associated with Plasmodium infection. The …

[HTML][HTML] Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against Plasmodium and Anopheles …

S Chaudhury, JS Bolton, LA Eller, M Robb… - Journal of Clinical …, 2022 - mdpi.com
Reliably assessing exposure to mosquitoes carrying malaria parasites continues to be a
challenge due to the lack of reliable, highly sensitive diagnostics with high-throughput potential. …

[HTML][HTML] Blast Waves Cause Immune System Dysfunction and Transient Bone Marrow Failure in a Mouse Model

ES Bergmann-Leitner, AG Bobrov, JS Bolton… - … in Bioengineering and …, 2022 - frontiersin.org
Explosive devices, either conventional or improvised, are common sources of injuries
during combat, civil unrest, and terror attacks, resulting in trauma and exposure to blast …

A spike-ferritin nanoparticle vaccine induces robust innate immune activity and drives polyfunctional SARS-CoV-2-specific T cells

…, RS Sankhala, WH Chen, WC Chang, JS Bolton… - BioRxiv, 2021 - biorxiv.org
Potent cellular responses to viral infections are pivotal for long -lived protection. Evidence is
growing that these responses are critical in SARS -CoV-2 immunity. Assessment of a SARS -…

[HTML][HTML] Immunoprofiling identifies functional B and T cell subsets induced by an attenuated whole parasite malaria vaccine as correlates of sterile immunity

…, P Lu, T Atre, JS Bolton, EH Duncan, S Chaudhury… - Vaccines, 2022 - mdpi.com
Immune correlates of protection remain elusive for most vaccines. An identified immune
correlate would accelerate the down-selection of vaccine formulations by reducing the need for …